• Users Online: 115
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2022  |  Volume : 8  |  Issue : 2  |  Page : 55-58

Bilastine up-dosing in chronic urticaria: A review


1 Department of Dermatology, Dr. DY Patil Medical College, Nerul, Navi Mumbai Maharashtra, India
2 Department of Dermatology, Apollo Hospital, Chennai, India
3 Department of Dermatology, BJ Medical College, Ahmedabad, Gujarat, India
4 Department of Dermatology, Max Super Speciality Hospital, New Delhi, India
5 Department of Dermatology, Krupa Shankar Skin Care Center, Mallige Hospital, Bengaluru, Karnataka, India
6 Department of Dermatology, Skin Diseases Center, Nashik, India
7 Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India
8 Department of Dermatology, The Medicity, Medanta Hospital, Gurugram, Haryana, India
9 Department of Dermatology, Hinduja Hospital, Mumbai, India
10 Department of Pharmacology, Dr. DY Patil Medical College, Nerul, Navi Mumbai, Maharashtra, India

Correspondence Address:
Kiran Godse
Department of Dermatology, Dr. DY Patil Medical College, Nerul, Navi Mumbai Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijdd.ijdd_30_21

Rights and Permissions

Chronic urticaria, a heterogenous skin condition can be difficult to treat in many patients. It can adversely affect patient’s quality of life. Bilastine is a useful armamentarium for the management of chronic urticaria. This second generation H1 antihistamine is distinguished from most of its counterparts. Non-sedating potential, fast onset and longer duration of action, less risk of drug interactions and once daily administration make it an attractive option for use. In patients with chronic urticaria, not showing satisfactory response to standard doses, its dose can be increased up to four fold. In this review, we discuss the evidence of higher dose of bilastine in chronic urticaria and its place in therapy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed570    
    Printed16    
    Emailed0    
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal